Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Nanotransfer logo — Developing the next generation delivery system for gene ther...

Nanotransfer

Developing the next generation delivery system for gene therapies

Founded 2021 Argentina Cordoba, Argentina 6 employees Pre Seed Total: $200.00K Biotechnology, Health Care

General Information

Company Name Nanotransfer
Founded Year 2021
Location Argentina Cordoba, Argentina +1
Employees 6
Industries Biotechnology, Health Care
Funding Stage Pre Seed
Social

Get notified when Nanotransfer moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Nanotransfer

Nanotransfer is a biotechnology startup based in Argentina, founded in 2021. The company's slogan "Developing the next generation delivery system for gene therapies" encapsulates its goal to revolutionize gene therapies through the development of an innovative gene delivery system. In December 2021, Nanotransfer secured a significant $200.00K Pre Seed Round investment from GRIDX, demonstrating notable interest and support from investors in the biotechnology and healthcare industries. With a promising focus on cutting-edge gene delivery technology, Nanotransfer has potential to make a substantial impact in the field of gene therapies.

Taxonomy: Gene therapies, Delivery system, Nanotransfer, Gene delivery system, Healthcare innovation, Medical technology, Genetic engineering, Biopharmaceuticals, Life sciences, Innovative healthcare solutions

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Pre Seed Round •••••• 1
Investor
25 Dec 2021

Nanotransfer Alternatives & Competitors

Nanotransfer vs
Cardion
Cardion

Pioneering cardiovascular gene therapy with advanced gene delivery, stem cell engineering, and toler...

Series Unknown
Biopharma, Biotechnology
Nanotransfer vs
Basilard BioTech, Inc.
Basilard BioTech, Inc. United States

Nanomechanical Gene Delivery to Transform the Engineering of Cell Based Therapies

Seed
5 employees
Biopharma, Biotechnology
Nanotransfer vs
AlveoGene
AlveoGene

Transforming Rare Respiratory Disease Outcomes Using Inhaled Genes Therapy

Seed
3 employees
Biotechnology, Health Care

FAQ About Nanotransfer

Developing the next generation delivery system for gene therapies
Nanotransfer was founded in 2021.
Nanotransfer is headquartered in Cordoba, Argentina.
Nanotransfer operates in the following industries: Biotechnology, Health Care.
Nanotransfer has approximately 6 employees.
Nanotransfer has completed 1 funding round, raising a total of $200.00K. The latest funding stage is Pre Seed.
Top alternatives and competitors to Nanotransfer include Cardion, Basilard BioTech, Inc., AlveoGene, VectorBuilder, Integra Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Nanotransfer and Cardion are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Nanotransfer and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy